October 14th, 20200(REUTERS) — Eli Lilly and Co. said on Tuesday that the government-sponsored clinical trial of its COVID-19 antibody treatment similar to one taken by President Trump has been paused by the U.S. government because of a safety concern.
Trump touted the Lilly drug, along with the antibody treatment from Regeneron Pharmaceuticals Inc....
